Yuhan Corporation: all 172 studies

Page 2 of 2. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke PatientsCompletedNCT03823274
• Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy VolunteersCompletedNCT03764462Phase 1
• Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy VolunteersCompletedNCT03662620Phase 1
• Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid TumorsCompletedNCT03644056Phase 1
• Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072CompletedNCT03632668Phase 1
• Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DMCompletedNCT03597412Phase 4
• Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012CompletedNCT03586037Phase 1
• Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448CompletedNCT03556436Phase 1
• HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With ProteinuriaStatus unknownNCT03550859Phase 4
• A Study to Evaluate the Effect of Sarpogrelate on Blood HyperviscosityCompletedNCT03509922Phase 4
• High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD PatientsCompletedNCT03494270Phase 4
• High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and HypertensionCompletedNCT03474562Phase 4
• Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and HypercholesterolemiaCompletedNCT03446261Phase 4
• Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's DementiaStatus unknownNCT03441516Phase 4
• High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 DiabetesStatus unknownNCT03403556Phase 4
• A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease PatientsCompletedNCT03334916Phase 4
• Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With HypertensionCompletedNCT03267329Phase 4
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706CompletedNCT03235362Phase 1
• Anagre Cap. in Patients With High-Risk Essential ThrombocythemiaCompletedNCT03232177Phase 4
• A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and HypercholesterolemiaCompletedNCT03217409Phase 4
• Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy VolunteersCompletedNCT03191136Phase 1
• Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and RosuvastatinCompletedNCT03116516Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of YHP1701CompletedNCT03103256Phase 3
• Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and HyperlipidemiaCompletedNCT03067688Phase 3
• Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLCCompletedNCT03046992Phase 1/2
• Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic PainCompletedNCT02985216Phase 3
• A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic SyndromeTerminatedNCT02968160Phase 4
• A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and RosuvastatinCompletedNCT02951962Phase 1
• A Clinical Trial of YH1177 in Patients With Otitis Media and OtorrheaTerminatedNCT02817347Phase 1/2
• PK and Food Effect of Pregabalin Study After Dosing in Healthy Male VolunteersCompletedNCT02783638Phase 1
• A Open-label, Randomized, Crossover Study to Assess PK of PregabalinCompletedNCT02783183Phase 1
• A Clinical Trial of YH23537 in Patients With Knee OsteoarthritisCompletedNCT02759198Phase 2
• Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine TreatmentCompletedNCT02620163Phase 3
• PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and RosuvastatinTerminatedNCT02608242Phase 1
• Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II DiabetesCompletedNCT02586129Phase 3
• A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.CompletedNCT02585596Phase 2
• A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional DyspepsiaTerminatedNCT02567578Phase 2
• Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional ConstipationCompletedNCT02538367Phase 1/2
• PK Study of YH22162 FDC Compared to Combination of Twynsta and HygrotonCompletedNCT02496910Phase 1
• Clinical Trial of YH14618 in Patients With Degenerative Disc DiseaseCompletedNCT02320019Phase 2
• The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersCompletedNCT02233218Phase 1
• The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy SubjectsCompletedNCT02176668Phase 1
• Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)CompletedNCT02152969Phase 1
• Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy VolunteersCompletedNCT02125227Phase 1
• A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy VolunteerCompletedNCT01992601Phase 1
• PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and RosuvastatinCompletedNCT01975961Phase 1
• The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy SubjectsCompletedNCT01921647Phase 1
• Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and HyperlipidemiaCompletedNCT01914432Phase 3
• Pharmacokinetic Drug Interaction Between YH4808 and DiclofenacCompletedNCT01876615Phase 1
• Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male SubjectsCompletedNCT01870674Phase 1
• Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)CompletedNCT01869881Phase 4
• AME Study of [14C]-YH4808 in Healthy Male SubjectsCompletedNCT01825707Phase 1
• YH4808 Postprandial PK/PD Study in Healthy SubjectsCompletedNCT01761513Phase 1
• Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)CompletedNCT01750437Phase 2
• Comparative Pharmacokinetics of YH14659 in Healthy Male SubjectsCompletedNCT01657071Phase 1
• Pharmacokinetic Drug Interaction Between Rosuvastatin and ValsartanCompletedNCT01609907Phase 1
• Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux EsophagitisCompletedNCT01538849Phase 2
• Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc DiseaseCompletedNCT01526330Phase 1/2
• A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy VolunteersCompletedNCT01526317Phase 1
• Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male VolunteersCompletedNCT01525147Phase 1
• Food Effect on Pharmacokinetics of YH4808 in Healthy Male SubjectsCompletedNCT01520012Phase 1
• Safety and Efficacy of YH14617 in Diabetes MellitusCompletedNCT01507038Phase 2
• A Clinical Trial of YH14642 in Patients With Chronic Periodontal DiseaseCompletedNCT01499225Phase 2
• Safety and Efficacy of YHD001 in AsthmaCompletedNCT01424124Phase 2
• Safety and Efficacy of YHD1023 in Erectile DysfunctionCompletedNCT01423370Phase 2
• Comparative Pharmacokinetics of YH14659CompletedNCT01422109Phase 1
• Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male SubjectsCompletedNCT01420913Phase 1
• Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic BronchitisCompletedNCT01420445Phase 2
• Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044CompletedNCT01419470Phase 1/2
• Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic RhinitisCompletedNCT01400828Phase 3
• Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male SubjectsCompletedNCT01332890Phase 1
• Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male SubjectsCompletedNCT01007019Phase 1

← Yuhan Corporation overview and focus areas